MTEM
$0.47
Molecular Templates
$.00
.06%
MTEM
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.24)
Revenue:  $2.57 Mil
Monday
Aug 14
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MTEM reports earnings?
Beat
Meet
Miss

Where is MTEM's stock price going from here?
Up
Flat
Down
Stock chart of MTEM
Analysts
Summary of analysts' recommendations for MTEM
Score
Grade
Pivots
Resistance
$0.51
$0.50
$0.49

$0.47

Support
$0.46
$0.45
$0.43
Tweet
Growth
Description
Molecular Templates Inc. is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies for the treatment of cancers and other serious diseases. Molecular Templates Inc., formerly known as Threshold Pharmaceuticals Inc., is headquartered in Austin, United States.